Cargando…
Adenoviruses as vaccine vectors
Adenoviruses have transitioned from tools for gene replacement therapy to bona fide vaccine delivery vehicles. They are attractive vaccine vectors as they induce both innate and adaptive immune responses in mammalian hosts. Currently, adenovirus vectors are being tested as subunit vaccine systems fo...
Autores principales: | Tatsis, Nia, Ertl, Hildegund C.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Gene Theraphy. Published by Elsevier Inc.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106330/ https://www.ncbi.nlm.nih.gov/pubmed/15451446 http://dx.doi.org/10.1016/j.ymthe.2004.07.013 |
Ejemplares similares
-
COVID-19 Vaccines Based on Adenovirus Vectors
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021) -
Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016) -
Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health
por: Ertl, Hildegund C. J., et al.
Publicado: (2022) -
Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
por: Xiang, Zhiquan, et al.
Publicado: (2006) -
T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)